Eton director sells 50,000 shares near $60
Eton Pharmaceuticals, Inc. (ETON) director Paul V. Maier reported multiple transactions on 2026-08-28.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4/A
Rhea-AI Filing Summary
Eton Pharmaceuticals, Inc. (ETON) director Paul V. Maier reported multiple transactions on 2026-08-28. He exercised employee stock options for 50,000 shares of common stock at an exercise price of $3.78 per share and 12,500 shares at $7.31 per share, receiving common stock.
On the same date, he sold an aggregate of 50,000 common shares in open-market transactions: 36,387 shares at a weighted average price of $58.64 (range $58.50–$58.97), 13,485 shares at $60.21 (range $60.00–$61.00), and 128 shares at $61.77 (range $61.10–$61.98).
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
7 txns
Insider
MAIER PAUL V
Role
Director
Sold
50,000 shs ($2.95M)
Approx. gross sale proceeds
$2.95M
Approx. exercise cost
$280K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option F3 | 50,000 | $0.00 | $0.00 |
| Exercise | Employee Stock Option F6 | 12,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 50,000 | $3.78 | $189K |
| Sale | Common Stock F1, F2 | 36,387 | $58.64 | $2.13M |
| Sale | Common Stock F1, F4 | 13,485 | $60.21 | $812K |
| Sale | Common Stock F1, F5 | 128 | $61.77 | $8K |
| Exercise | Common Stock | 12,500 | $7.31 | $91K |
Holdings After Transaction:
Employee Stock Option — 0 contracts (Direct);
Common Stock — 72,245 shares (Direct)
Footnotes (6)
- F1. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F2. The shares were sold in multiple trades at prices ranging from $58.50 to $58.97. The price reported above reflects the weighted average sales price.
- F3. The shares subject to the option vested in 48 equal monthly installments from the date of grant (2-07-2022) until fully vested.
- F4. The shares were sold in multiple trades at prices ranging from $60.00 to $61.00. The price reported above reflects the weighted average sales price.
- F5. The shares were sold in multiple trades at prices ranging from $61.10 to $61.98. The price reported above reflects the weighted average sales price.
- F6. The shares subject to the option vested in four equal quarterly installments from the date of grant (02-20-2019) until fully vested.
Key Figures
Options exercised - shares at $3.78: 50,000 shares at $3.78 per share
Options exercised - shares at $7.31: 12,500 shares at $7.31 per share
Common shares sold at $58.64: 36,387 shares at $58.64 per share
+5 more
8 metrics
Options exercised - shares at $3.78
50,000 shares at $3.78 per share
Employee Stock Option exercise into common stock on 2026-08-28
Options exercised - shares at $7.31
12,500 shares at $7.31 per share
Employee Stock Option exercise into common stock on 2026-08-28
Common shares sold at $58.64
36,387 shares at $58.64 per share
Open-market sale on 2026-08-28; trades ranged $58.50–$58.97
Common shares sold at $60.21
13,485 shares at $60.21 per share
Open-market sale on 2026-08-28; trades ranged $60.00–$61.00
Common shares sold at $61.77
128 shares at $61.77 per share
Open-market sale on 2026-08-28; trades ranged $61.10–$61.98
Total common shares sold
50,000 shares
Aggregate of three open-market sale tranches on 2026-08-28
Option grant vesting (2022 grant)
48 equal monthly installments from 2-07-2022
Vesting schedule for 50,000-share Employee Stock Option
Option grant vesting (2019 grant)
Four equal quarterly installments from 02-20-2019
Vesting schedule for 12,500-share Employee Stock Option
Key Terms
Employee Stock Option, Exercise or conversion of derivative security, weighted average sales price
3 terms
Employee Stock Option financial
"security_title: "Employee Stock Option""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
weighted average sales price financial
"The price reported above reflects the weighted average sales price."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did ETON director Paul V. Maier report on August 28, 2026?
He exercised options for 62,500 shares of ETON common stock (50,000 at $3.78, 12,500 at $7.31) and sold 50,000 shares in open-market trades at weighted average prices between $58.64 and $61.77, with price ranges detailed in the filing footnotes.
How many ETON options did Paul V. Maier exercise and at what strike prices?
He exercised employee stock options covering 50,000 shares at an exercise price of $3.78 per share and 12,500 shares at $7.31 per share, receiving ETON common stock upon exercise.
Were Paul V. Maier’s ETON transactions under a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox is marked false, and the footnotes do not reference a trading plan, so the reported August 28, 2026 transactions are not indicated as being made pursuant to a Rule 10b5-1 trading plan.
What vesting terms applied to the ETON options exercised by Paul V. Maier?
Footnotes state the 50,000-share option granted 2-07-2022 vested in 48 equal monthly installments, and the 12,500-share option granted 02-20-2019 vested in four equal quarterly installments until fully vested.
AI-generated analysis. How Rhea-AI works. Not financial advice.
